Intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) contribute to the elimination of equine herpesvirus type 1 (EHV-1) from the lungs of intranasally infected BALB/c mice.

[1]  P. Openshaw,et al.  Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.

[2]  Patrick M. Smith,et al.  Severe Murine Lung Immunopathology Elicited by the Pathogenic Equine Herpesvirus 1 Strain RacL11 Correlates with Early Production of Macrophage Inflammatory Proteins 1α, 1β, and 2 and Tumor Necrosis Factor Alpha , 2000, Journal of Virology.

[3]  J. Gilkerson,et al.  Primary and challenge infection of mice with equine herpesvirus 1, strain HSV25A. , 1998, Virus research.

[4]  K. Maeda,et al.  Diagnosis and sero-epizootiology of equine herpesvirus type 1 and type 4 infections in Japan using a type-specific ELISA. , 1998, The Journal of veterinary medical science.

[5]  Patrick M. Smith,et al.  Characterization of the Cytolytic T-Lymphocyte Response to a Candidate Vaccine Strain of Equine Herpesvirus 1 in CBA Mice , 1998, Journal of Virology.

[6]  J. Gilkerson,et al.  Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. , 1998, Veterinary microbiology.

[7]  T. Matsumura,et al.  An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. , 1998, Virology.

[8]  M. Isobe,et al.  Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease. , 1997, International immunology.

[9]  T. Matsumura,et al.  Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. , 1996, Veterinary microbiology.

[10]  H. Field,et al.  Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. , 1996, Virus research.

[11]  S. Yamamoto,et al.  Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. , 1995, International journal of experimental pathology.

[12]  R. A. Killington,et al.  Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice. , 1995, Research in veterinary science.

[13]  A. Finnegan,et al.  Involvement of LFA-1 and ICAM-1 in the herpetic disease resulting from HSV-1 corneal infection. , 1995, Current eye research.

[14]  C. Kelling,et al.  Viral infection of bovine bronchial epithelial cells induces increased neutrophil chemotactic activity and neutrophil adhesion. , 1993, Clinical science.

[15]  B. Crabb,et al.  Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host , 1993, Journal of virology.

[16]  H. Field,et al.  Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells. , 1993, The Journal of general virology.

[17]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[18]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[19]  L. Osborn,et al.  Leukocyte adhesion to endothelium in inflammation , 1990, Cell.

[20]  A. Awan,et al.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. , 1990, The Journal of general virology.

[21]  N. Nowotny,et al.  Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. , 1990, The Veterinary quarterly.

[22]  Michael Loran Dustin,et al.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells , 1988, The Journal of cell biology.

[23]  J. Jackson,et al.  Leukocyte-induced tissue injury. , 1988, Hematology/oncology clinics of North America.

[24]  T. Springer,et al.  ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.

[25]  Michael Loran Dustin,et al.  The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. , 1987, Annual review of immunology.

[26]  W. W. Douglas.  The Pulmonary Circulation and Acute Lung Injury , 1986 .

[27]  D. Goodridge,et al.  Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus , 1984, Veterinary Record.